FMC
520 hedge funds and large institutions have $10.8B invested in FMC in 2017 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 181 increasing their positions, 183 reducing their positions, and 44 closing their positions.
82% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 44
21% more capital invested
Capital invested by funds: $8.91B → $10.8B (+$1.88B)
15% more funds holding in top 10
Funds holding in top 10: 13 → 15 (+2)
7% more funds holding
Funds holding: 487 → 520 (+33)
1% less repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 183
1.29% less ownership
Funds ownership: 105.17% → 103.88% (-1.3%)
12% less call options, than puts
Call options by funds: $38.4M | Put options by funds: $43.7M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$143M |
| 2 |
GXMC
Global X Management Company
New York
|
+$88.7M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$47.5M |
| 4 |
Goldman Sachs
New York
|
+$43.4M |
| 5 |
Two Sigma Investments
New York
|
+$40.1M |
Top Sellers
FMC Hedge Fund Activity: Q3 2017 in Review
520 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in FMC (FMC) for Q3 2017, worth a combined $10.8B — up 21% from $8.91B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new FMC positions and 44 closed out — a net gain of 36 holders — while 181 added to existing stakes and 183 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $143M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $180M.
- 520 institutional investors held FMC (FMC) as of Q3 2017, up from 487 in Q2 2017.
- Funds reported $10.8B of FMC stock for Q3 2017, up 21% quarter-over-quarter.
- 80 funds opened new FMC positions in Q3 2017 and 44 closed out, a net change of +36 holders.
- The largest FMC buyer in Q3 2017 was Fidelity Investments, an estimated $143M added.
- The largest FMC seller in Q3 2017 was Barrow, Hanley, Mewhinney & Strauss, an estimated $180M sold.
Based on aggregated 13F filings for Q3 2017.